Literature DB >> 17197511

Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.

Weiqin Chen1, Donald B Jump, Walter J Esselman, Julia V Busik.   

Abstract

PURPOSE: Docosahexaenoic acid (DHA(22:6,n3)) is the principal n3 polyunsaturated fatty acid (PUFA) in the retina. The authors previously demonstrated that DHA(22:6,n3) inhibited cytokine-induced adhesion molecule expression in primary human retinal vascular endothelial (hRVE) cells, the target tissue affected by diabetic retinopathy. Despite the importance of vascular inflammation in diabetic retinopathy, the mechanisms underlying anti-inflammatory effects of DHA(22:6,n3) in vascular endothelial cells are not understood. In this study the authors address the hypothesis that DHA(22:6,n3) acts through modifying lipid composition of caveolae/lipid rafts, thereby changing the outcome of important signaling events in these specialized plasma membrane microdomains.
METHODS: hRVE cells were cultured in the presence or absence of DHA(22:6,n3). Isolated caveolae/lipid raft-enriched detergent-resistant membrane domains were prepared using sucrose gradient ultracentrifugation. Fatty acid composition and cholesterol content of caveolae/lipid rafts before and after treatment were measured by HPLC. The expression of Src family kinases was assayed by Western blotting and immunohistochemistry.
RESULTS: Disruption of the caveolae/lipid raft structure with a cholesterol-depleting agent, methyl-cyclodextrin (MCD), diminished cytokine-induced signaling in hRVE cells. Growth of hRVE cells in media enriched in DHA(22:6,n3) resulted in significant incorporation of DHA(22:6,n3) into the major phospholipids of caveolae/lipid rafts, causing an increase in the unsaturation index in the membrane microdomain. DHA(22:6,n3) enrichment in the caveolae/raft was accompanied by a 70% depletion of cholesterol from caveolae/lipid rafts and displacement of the SFK, Fyn, and c-Yes from caveolae/lipid rafts. Adding water-soluble cholesterol to DHA(22:6,n3)-treated cells replenished cholesterol in caveolae/lipid rafts and reversed the effect of DHA(22:6,n3) on cytokine-induced signaling.
CONCLUSIONS: Incorporation of DHA(22:6,n3) into fatty acyl chains of phospholipids in caveolae/lipid rafts, followed by cholesterol depletion and displacement of important signaling molecules, provides a potential mechanism for anti-inflammatory effect of DHA(22:6,n3) in hRVE cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197511      PMCID: PMC1975816          DOI: 10.1167/iovs.06-0619

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  83 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Purification of caveolae-derived membrane microdomains containing lipid-anchored signaling molecules, such as GPI-anchored proteins, H-Ras, Src-family tyrosine kinases, eNOS, and G-protein alpha-, beta-, and gamma-subunits.

Authors:  M P Lisanti; M Sargiacomo; P E Scherer
Journal:  Methods Mol Biol       Date:  1999

3.  TNF-alpha-mediated apoptosis is initiated in caveolae-like domains.

Authors:  Y G Ko; J S Lee; Y S Kang; J H Ahn; J S Seo
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

4.  Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src.

Authors:  H He; V J Venema; X Gu; R C Venema; M B Marrero; R B Caldwell
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

5.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

6.  VEGF-induced permeability increase is mediated by caveolae.

Authors:  Y Feng; V J Venema; R C Venema; N Tsai; M A Behzadian; R B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

Review 7.  Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes?

Authors:  D A Brown; E London
Journal:  Biochem Biophys Res Commun       Date:  1997-11-07       Impact factor: 3.575

8.  Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids.

Authors:  R De Caterina; W Bernini; M A Carluccio; J K Liao; P Libby
Journal:  J Lipid Res       Date:  1998-05       Impact factor: 5.922

9.  T lymphocyte costimulation mediated by reorganization of membrane microdomains.

Authors:  A Viola; S Schroeder; Y Sakakibara; A Lanzavecchia
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

10.  Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains.

Authors:  T M Stulnig; M Berger; T Sigmund; D Raederstorff; H Stockinger; W Waldhäusl
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  43 in total

1.  Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Authors:  Xiaoman Li; Xiaowu Gu; Timothy M Boyce; Min Zheng; Alaina M Reagan; Hui Qi; Nawajes Mandal; Alex W Cohen; Michelle C Callegan; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

Review 2.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

3.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.

Authors:  Sasmita Tripathy; Moises Torres-Gonzalez; Donald B Jump
Journal:  J Lipid Res       Date:  2010-05-19       Impact factor: 5.922

Review 4.  ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.

Authors:  Yan Gong; Zhongjie Fu; Raffael Liegl; Jing Chen; Ann Hellström; Lois Eh Smith
Journal:  Am J Clin Nutr       Date:  2017-05-17       Impact factor: 7.045

Review 5.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

Review 6.  Fatty acid-regulated transcription factors in the liver.

Authors:  Donald B Jump; Sasmita Tripathy; Christopher M Depner
Journal:  Annu Rev Nutr       Date:  2013-03-22       Impact factor: 11.848

Review 7.  Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine.

Authors:  Robert S Chapkin; Jeongmin Seo; David N McMurray; Joanne R Lupton
Journal:  Chem Phys Lipids       Date:  2008-03-04       Impact factor: 3.329

Review 8.  Docosahexaenoic acid (DHA) and hepatic gene transcription.

Authors:  Donald B Jump; Daniela Botolin; Yun Wang; Jinghua Xu; Olivier Demeure; Barbara Christian
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

Review 9.  The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants.

Authors:  Zuzana Majkova; Michal Toborek; Bernhard Hennig
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

10.  Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.

Authors:  Madalina Opreanu; Todd A Lydic; Gavin E Reid; Kelly M McSorley; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.